Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
μMap Photoproximity Labeling Enables Small Molecule Binding Site Mapping.
Huth SW, Oakley JV, Seath CP, Geri JB, Trowbridge AD, Parker DL Jr, Rodriguez-Rivera FP, Schwaid AG, Ramil C, Ryu KA, White CH, Fadeyi OO, Oslund RC, MacMillan DWC. Huth SW, et al. Among authors: parker dl jr. J Am Chem Soc. 2023 Aug 2;145(30):16289-16296. doi: 10.1021/jacs.3c03325. Epub 2023 Jul 20. J Am Chem Soc. 2023. PMID: 37471577
Small molecule photocatalysis enables drug target identification via energy transfer.
Trowbridge AD, Seath CP, Rodriguez-Rivera FP, Li BX, Dul BE, Schwaid AG, Buksh BF, Geri JB, Oakley JV, Fadeyi OO, Oslund RC, Ryu KA, White C, Reyes-Robles T, Tawa P, Parker DL Jr, MacMillan DWC. Trowbridge AD, et al. Among authors: parker dl jr. Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2208077119. doi: 10.1073/pnas.2208077119. Epub 2022 Aug 15. Proc Natl Acad Sci U S A. 2022. PMID: 35969791 Free PMC article.
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor.
Apgar JM, Wilkening RR, Parker DL Jr, Meng D, Wildonger KJ, Sperbeck D, Greenlee ML, Balkovec JM, Flattery AM, Abruzzo GK, Galgoci AM, Giacobbe RA, Gill CJ, Hsu MJ, Liberator P, Misura AS, Motyl M, Nielsen Kahn J, Powles M, Racine F, Dragovic J, Fan W, Kirwan R, Lee S, Liu H, Mamai A, Nelson K, Peel M. Apgar JM, et al. Among authors: parker dl jr. Bioorg Med Chem Lett. 2021 Jan 15;32:127661. doi: 10.1016/j.bmcl.2020.127661. Epub 2020 Nov 4. Bioorg Med Chem Lett. 2021. PMID: 33160023
MK-5204: An orally active β-1,3-glucan synthesis inhibitor.
Apgar JM, Wilkening RR, Parker DL Jr, Meng D, Wildonger KJ, Sperbeck D, Greenlee ML, Balkovec JM, Flattery AM, Abruzzo GK, Galgoci AM, Giacobbe RA, Gill CJ, Hsu MJ, Liberator P, Misura AS, Motyl M, Kahn JN, Powles M, Racine F, Dragovic J, Fan W, Kirwan R, Lee S, Liu H, Mamai A, Nelson K, Peel M. Apgar JM, et al. Among authors: parker dl jr. Bioorg Med Chem Lett. 2020 Sep 1;30(17):127357. doi: 10.1016/j.bmcl.2020.127357. Epub 2020 Jun 19. Bioorg Med Chem Lett. 2020. PMID: 32738971
Microenvironment mapping via Dexter energy transfer on immune cells.
Geri JB, Oakley JV, Reyes-Robles T, Wang T, McCarver SJ, White CH, Rodriguez-Rivera FP, Parker DL Jr, Hett EC, Fadeyi OO, Oslund RC, MacMillan DWC. Geri JB, et al. Among authors: parker dl jr. Science. 2020 Mar 6;367(6482):1091-1097. doi: 10.1126/science.aay4106. Science. 2020. PMID: 32139536 Free PMC article.
Cyp1 Inhibition Prevents Doxorubicin-Induced Cardiomyopathy in a Zebrafish Heart-Failure Model.
Lam PY, Kutchukian P, Anand R, Imbriglio J, Andrews C, Padilla H, Vohra A, Lane S, Parker DL Jr, Cornella Taracido I, Johns DG, Beerens M, MacRae CA, Caldwell JP, Sorota S, Asnani A, Peterson RT. Lam PY, et al. Among authors: parker dl jr. Chembiochem. 2020 Jul 1;21(13):1905-1910. doi: 10.1002/cbic.201900741. Epub 2020 Mar 6. Chembiochem. 2020. PMID: 32003101 Free PMC article.
Treatment of Hyponatremia in Patients with Acute Neurological Injury.
Human T, Cook AM, Anger B, Bledsoe K, Castle A, Deen D, Gibbs H, Lesch C, Liang N, McAllen K, Morrison C, Parker D Jr, Rowe AS, Rhoney D, Sangha K, Santayana E, Taylor S, Tesoro E, Brophy G. Human T, et al. Among authors: parker d jr. Neurocrit Care. 2017 Oct;27(2):242-248. doi: 10.1007/s12028-016-0343-x. Neurocrit Care. 2017. PMID: 28054290
Development of a novel class of potent and selective FIXa inhibitors.
Zhang T, Andre P, Bateman TJ, Chen YH, Desai K, Ellsworth K, Geissler WM, Guo L, Hruza A, Jian T, Meng D, Parker DL Jr, Qian X, Reichert P, Sherer EC, Shu M, Smith CJ, Sonatore LM, Tschirret-Guth R, Nolting AF, Orr R, Campeau LC, Araki K, Nishimura T, Sakurada I, Wood HB. Zhang T, et al. Among authors: parker dl jr. Bioorg Med Chem Lett. 2015 Nov 1;25(21):4945-4949. doi: 10.1016/j.bmcl.2015.04.057. Epub 2015 Apr 29. Bioorg Med Chem Lett. 2015. PMID: 25978966
31 results